drugset / Trial / NCT03796364

Clinical Study of Endostatin in Improving Radiation Pneumonia and Fibrosis

NCT03796364

Phase 2 Completed 126 enrolled Xinqiao Hospital of Chongqing
RandomizedParallel-groupOpen-labelTreatment

Summary

To verify the efficacy and safety of endostatin in the treatment of SRILI(symptomatic radiation-induced lung injury) and fibrosis. The results of this study are expected to be a new clinical strategy for the treatment of radiation pneumonia and fibrosis.

Timeline

Start
2018-09-01
Primary completion
2020-05-31
Completion
2020-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Endostar Protein / enzyme biologic Intravenous